Company / Working Capital per Share
RAPT Therapeutics, Inc. Working Capital per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.58
FY2024
5-year range
$3.65 / $7.33
FY2020-FY2024
Trend
+25.6%
vs FY2023
Sector context
#110 of 208
Health Care
What the data says
At $4.58, RAPT Therapeutics, Inc.'s working capital per share ranks #110 of 208 in the Health Care sector. Working Capital per Share has fluctuated over the past 7 years, ranging from $3.65 in FY2023 to $97.09 in FY2018.
Based on SEC 10-K filings.
4.58 in FY2024 with a 5-year CAGR of -22.5%.
Declined from $7.33 to $4.58 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- -22.5%
- 10-Year CAGR
- -
Sector benchmark
#110 of 208 in Health CareTop 53% of 208This company $4.58 Sector average $160.16
▼
-97.1% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 25.6% year-over-year.
- Ranks #110 out of 208 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.58 | +25.6% |
| FY2023 | $3.65 | -50.2% |
| FY2022 | $7.33 | +9.5% |
| FY2021 | $6.69 | +55.6% |
| FY2020 | $4.30 | -73.7% |
| FY2019 | $16.39 | -83.1% |
| FY2018 | $97.09 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026